Suppr超能文献

医学期刊编辑和同行评审员的利益冲突政策:横断面研究

Conflict of interest policies for editors and peer reviewers in medical journals:cross-sectional study.

作者信息

Korfitsen Christoffer Bruun, Van Beersel Krejcikova Helena, Nejstgaard Camilla Hansen, Boutron Isabelle, Bero Lisa, Hróbjartsson Asbjørn, Lundh Andreas

机构信息

Cochrane Denmark & Centre for Evidence-Based Medicine Odense (CEBMO), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark.

Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), F-75004 Paris, France; Centre d'Épidémiologie Clinique, Hôpital Hôtel Dieu, AP-HP, F-75004 Paris, France.

出版信息

J Clin Epidemiol. 2025 Sep 19:111980. doi: 10.1016/j.jclinepi.2025.111980.

Abstract

OBJECTIVES

Editors and reviewers of research manuscripts may have conflicts of interest that impact their evaluations. We aimed to characterise medical journals' conflict of interest policies for editors and peer reviewers.

STUDY DESIGN AND SETTING

In this cross-sectional study, we randomly sampled 277 medical journals from Clarivate Journal Citation Reports. Two authors independently retrieved public conflict of interest policies and disclosures for editors and peer reviewers from journal websites, and retrieved publishers' policies when journals also referred to them (January to June 2024). We used content analysis to analyse policies and multivariable mixed-effects logistic regressions to estimate the associations between journal characteristics and having a policy.

RESULTS

After excluding 27 journals, we included 250 medical journals in English, of which 177 (71%) had a conflict of interest policy for editors and 174 (70%) for peer reviewers. Of journals with a policy, 137 (77%) and 129 (74%) described disclosure requirements, 160 (90%) and 163 (94%) management strategies, 124 (70%) and 106 (61%) policy enforcement strategies, and 17 (10%) and 15 (9%) processes for appealing decisions. All four concepts were addressed in 16 (9%) policies for editors and 11 (6%) for peer reviewers. Having a policy for editors was associated with higher journal impact factor (adjusted odds ratio (OR): 1.28; 95% confidence interval (CI): 1.05-1.56) and Committee on Publication Ethics (COPE) membership (OR: 3.50; 95% CI: 1.42-8.65). Having a policy for peer reviewers was associated with higher journal impact factor (OR: 1.16; 95% CI: 0.97-1.37) and open access journal (OR: 4.59; 95% CI: 1.11-18.93). For a subgroup of journals referring to their publishers' policy, the content was concordant for 5 (11%) of 45 journals for editors and 4 (9%) of 47 journals for peer reviewers. Of 250 journals, 14 (6%) had public declarations of interest from editors, and 3 (1%) from peer reviewers.

CONCLUSION

More than two-thirds of medical journals have conflict of interest policies for editors and reviewers; however, policies vary in comprehensiveness. There is potential to improve the content of conflict of interest policies and the transparency of interests in medical journals.

PLAIN LANGUAGE SUMMARY

Before a scientific study is published as a research paper in a medical journal, it is evaluated by the journal editors and other researchers, known as peer reviewers. This process is used to assess and ensure the quality and trustworthiness of the research, and to assist editors in deciding whether to publish the paper. Editors and peer reviewers, however, are not necessarily neutral and may have personal interests that can influence their opinions. For example, they may have personal relationships with the study authors or have financial relationships with a company whose product is investigated in the study, which could result in conflicts of interest. Although most journals have policies addressing study authors' conflicts of interest, little is known about the practices and policies of medical journals concerning editors' and peer reviewers' conflicts of interest. In our study, we randomly selected 250 medical journals and examined their public conflict of interest policies for editors and peer reviewers, as well as whether these policies aligned with their publishers' policies. Additionally, we assessed whether the interests of editors and peer reviewers were publicly disclosed. We estimated the proportion of journals with available policies, assessed which journal characteristics were associated with having a policy, and analysed the content of policies. Of the 250 medical journals, we found that 177 (71%) journals had a conflict of interest policy for editors and 174 (70%) for peer reviewers, but their interests were very rarely publicly disclosed. The policies often contained limited information and were often only described in detail in the publishers' policies, and sometimes information in the journal's and the publisher's policies was in disagreement. Finally, policies rarely describe how journal staff assess interests, how these assessments may influence the journal's editorial process, and how journals enforce the consequences of policy violations. There is substantial potential for medical journals to improve their conflict of interest policies for editors and peer reviewers, as well as the transparency of their interests in medical journals.

摘要

目的

研究稿件的编辑和评审人员可能存在利益冲突,从而影响他们的评估。我们旨在描述医学期刊针对编辑和同行评审人员的利益冲突政策。

研究设计与背景

在这项横断面研究中,我们从科睿唯安期刊引证报告中随机抽取了277种医学期刊。两位作者独立从期刊网站上检索编辑和同行评审人员的公开利益冲突政策及披露信息,并在期刊提及出版商政策时检索出版商的政策(2024年1月至6月)。我们采用内容分析法分析政策,并使用多变量混合效应逻辑回归来估计期刊特征与拥有某项政策之间的关联。

结果

排除27种期刊后,我们纳入了250种英文医学期刊,其中177种(71%)有针对编辑的利益冲突政策,174种(70%)有针对同行评审人员的政策。在有政策的期刊中,137种(77%)和129种(74%)描述了披露要求,160种(90%)和163种(94%)描述了管理策略,124种(70%)和106种(61%)描述了政策执行策略,17种(10%)和15种(9%)描述了决定申诉流程。在针对编辑的政策中有16种(9%)、针对同行评审人员的政策中有11种(6%)涉及了所有这四个概念。拥有针对编辑的政策与较高的期刊影响因子(调整后的优势比(OR):1.28;95%置信区间(CI):1.05 - 1.56)以及出版伦理委员会(COPE)成员身份(OR:3.50;95% CI:1.42 - 8.65)相关。拥有针对同行评审人员的政策与较高的期刊影响因子(OR:1.16;95% CI:0.97 - 1.37)以及开放获取期刊(OR:4.59;95% CI:1.11 - 18.93)相关。对于提及出版商政策的期刊子组,45种针对编辑的期刊中有5种(11%)、47种针对同行评审人员的期刊中有4种(9%)内容一致。在250种期刊中,14种(6%)有编辑的利益公开声明,3种(1%)有同行评审人员的利益公开声明。

结论

超过三分之二的医学期刊有针对编辑和评审人员的利益冲突政策;然而,政策的全面性各不相同。医学期刊在改善利益冲突政策内容及利益透明度方面仍有潜力。

通俗易懂的总结

在一项科学研究以研究论文形式在医学期刊上发表之前,它会由期刊编辑和其他研究人员(即同行评审人员)进行评估。这个过程用于评估和确保研究的质量与可信度,并协助编辑决定是否发表该论文。然而,编辑和同行评审人员不一定是中立的,可能存在个人利益影响他们意见。例如,他们可能与研究作者有个人关系,或者与研究中所调查产品的公司有财务关系,这可能导致利益冲突。尽管大多数期刊有处理研究作者利益冲突的政策,但对于医学期刊关于编辑和同行评审人员利益冲突的做法和政策却知之甚少。在我们的研究中,我们随机选择了250种医学期刊,检查了它们针对编辑和同行评审人员的公开利益冲突政策,以及这些政策是否与出版商政策一致。此外,我们评估了编辑和同行评审人员的利益是否公开披露。我们估计了有可用政策的期刊比例,评估了哪些期刊特征与拥有某项政策相关,并分析了政策内容。在250种医学期刊中,我们发现177种(71%)期刊有针对编辑的利益冲突政策,174种(70%)有针对同行评审人员的政策,但他们的利益很少公开披露。这些政策通常包含的信息有限,且往往仅在出版商政策中有详细描述,有时期刊政策和出版商政策中的信息不一致。最后,政策很少描述期刊工作人员如何评估利益、这些评估如何可能影响期刊的编辑过程,以及期刊如何执行违反政策的后果。医学期刊在改善针对编辑和同行评审人员的利益冲突政策以及医学期刊利益透明度方面有很大潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验